S3-E10.1 - NAFLD and NASH Prevalence and Advanced Liver Fibrosis in Germany

Send us Fan MailEpisode 10 dives into recent NAFLD and NASH Prevalence studies in the US, UK and Germany and explores what this can tell us about who to screen for NAFLD and NASH, when to screen first and how often to screen after that. This conversation focuses on the paper Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in Germany, which was published last Saturday in Hepatology Communications. Last author Jörn Schattenberg presents results of the paper, after which panelist Ian Rowe and Wayne Eskridge ask the role that FIB-4 played in the study and analysis and Roger Green asks Professor Schattenberg what significance to apply to a Fatty Liver Index >60 in 3/8 of the sample.